Free tool
Drugs in development
Last checked: Nov 20, 2026Latest source record: rebuilt Nov 18, 2026Source: ClinicalTrials.govMethods & limitations
Drugs in development
3,685
Not FDA-approved
In Phase 3
1,424
Highest phase reached
Matching your filters
1,268
1,268 drugs in development
Names, sponsors and conditions come from the trial records. Click a drug for its trials.
- MR001Phase 21 trial
Shenzhen Majory Biotechnology Co., Ltd. · Pancreatic Ductal Adenocarcinoma (PDAC)
- MRG007Phase 21 trial
Lepu Biopharma Co., Ltd. · Advanced Colorectal Cancer
- MT-4561Phase 21 trial
Tanabe Pharma America, Inc. · Head and Neck Squamous Cell Carcinoma (HNSCC), Non-small Cell Lung Cancer (NSCLC), Esophageal Cancer
- MVA-209-FSPPhase 21 trial
Nouscom SRL · Solid Tumor, Adult
- N17350Phase 21 trial
Onchilles Pharma Inc · Neoplasms, Solid Tumor, Breast Neoplasms, Triple-Negative, Squamous Cell Carcinoma of Skin
- Nab-placlitaxelPhase 21 trial
BioNTech SE · Locally Advanced Breast Cancer, Triple Negative Breast Cancer, Metastatic Triple Negative Breast Cancers
- NadunolimabCAN04Phase 21 trial
Cantargia AB · Triple Negative Breast Cancer
- narmafotinibPhase 21 trial
Amplia Therapeutics Limited · Pancreatic Cancer Metastatic
- NazartinibEGF816Phase 21 trial
Novartis · Advanced Solid Tumors Which Are cMET-dependent
- NBQ72SQBS10072SPhase 21 trial
Nantong Bencao Quadriga Medical Technology Co. Ltd. · Breast Cancer
- NDI-101150Phase 21 trial
Nimbus Saturn, Inc. · Solid Tumor, Renal Cell Carcinoma (Kidney Cancer), Gastric and Gastroesophageal Junction (GEJ) Adenocarcinoma
- NDI-219216Phase 21 trial
Nimbus Wadjet, Inc. · Advanced Solid Tumors Cancer, MSI-H Cancer
- NemvaleukinALKS 4230Phase 21 trial
Mural Oncology, Inc · Advanced Solid Tumor
- NEO-201Phase 21 trial
Precision Biologics, Inc · Non Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma, Cervical Cancer
- NEO212POH-TMZPhase 21 trial
Neonc Technologies, Inc. · Diffuse Astrocytoma, IDH-Mutant, Glioblastoma, IDH-wildtype, Brain Metastases, Adult
- NG101mPhase 21 trial
NeuGATE Theranostics · Glioblastoma Multiforme
- NGM120Phase 21 trial
NGM Biopharmaceuticals, Inc · Colorectal Cancer, CRC (Colorectal Cancer), Cancer Cachexia
- NHT102Phase 21 trial
Nob Hill Therapeutics, Inc. · NSCLC (Advanced Non-small Cell Lung Cancer)
- NKT2152Phase 21 trial
Roche (Genentech) · Advanced Liver Cancers
- NKTR-255Phase 21 trial
EMD Serono Research & Development Institute, Inc. · Locally Advanced or Metastatic Urothelial Carcinoma
- NP137Phase 21 trial
NETRIS Pharma · Endometrial Carcinoma, Cervix Carcinoma
- NRC-2694-APhase 21 trial
NATCO Pharma Ltd. · Carcinoma, Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma
- NTS071Phase 21 trial
Nutshell Therapeutics (Shanghai) Co., LTD. · Advanced Solid Tumors
- NUV-1511Phase 21 trial
Nuvation Bio Inc. · Advanced Solid Tumor, HER2-negative Breast Cancer, Metastatic Castration-resistant Prostate Cancer (mCRPC)
- OBI-902Phase 21 trial
OBI Pharma, Inc · Advanced Solid Tumor
- OBI-992Phase 21 trial
OBI Pharma, Inc · Advanced Solid Tumor
- OBX-115Phase 21 trial
Obsidian Therapeutics, Inc. · Tumor Skin, Metastatic Melanoma, Melanoma
- ODM-216Phase 21 trial
Orion Corporation, Orion Pharma · Advanced Solid Tumors Cancer
- OKI-179Phase 21 trial
OnKure, Inc. · RAS Mutation, NRAS Gene Mutation, Melanoma
- ONO-4538HSCPhase 21 trial
Ono Pharmaceutical Co., Ltd. · Pediatric Malignant Solid Tumor and Epithelioid Sarcoma
- ONO-7703Phase 21 trial
Ono Pharmaceutical Co., Ltd. · Pan-tumor
- OPM-101Phase 21 trial
Oncodesign Precision Medicine · Advanced Melanoma
- OR502Phase 21 trial
OncoResponse, Inc. · Cancer, Tumor, Solid, Malignant Neoplasm
- ORIC-114Phase 21 trial
ORIC Pharmaceuticals · Solid Tumors
- OSE-279Phase 21 trial
OSE Immunotherapeutics · Solid Advanced Tumor, Lymphoma, NSCLC (Non-small Cell Lung Cancer)
- OST31-164Phase 21 trial
Emerald Clinical Inc. · Bone Cancer
- OTP-01Phase 21 trial
Ottimo Pharma Limited · Advanced Solid Tumors
- PBP1510Phase 21 trial
Prestige Biopharma Limited · Pancreatic Cancer
- PE0105Phase 21 trial
Shanghai YingLi Pharmaceutical Co. Ltd. · Advanced Solid Tumors
- PE0116Phase 21 trial
Shanghai YingLi Pharmaceutical Co. Ltd. · Advanced Solid Tumors
- PEGPH20Phase 21 trial
Roche (Genentech) · Pancreatic Adenocarcinoma
- PempulimabPhase 21 trial
Chia Tai Tianqing Pharmaceutical Group Co., Ltd. · Nasopharyngeal Carcinoma
- PepinemabPhase 21 trial
Vaccinex Inc. · Metastatic Pancreatic Adenocarcinoma
- PF-0704091Phase 21 trial
Pfizer · Small Cell Lung Cancer, Ovarian Cancer, Breast Cancer
Genelux Corporation · Advanced Non-squamous Non-small-cell Lung Cancer, Advanced Squamous Non-Small Cell Lung Carcinoma, Metastatic Non-squamous Non Small Cell Lung Cancer
- PlixorafenibFORE8394, PLX-8394Phase 21 trial
Fore Biotherapeutics · Cancer Harboring BRAF Alterations, HGG, LGG
- PM1009Phase 21 trial
Biotheus Inc. · HCC, Liver Cancer
- PMD-026Phase 21 trial
Phoenix Molecular Designs · Metastatic Breast Cancer
- preferred combination of tinengotinibPhase 21 trial
TransThera Sciences (Nanjing), Inc. · Prostate Cancer (CRPC)
- PRGN-2009Phase 21 trial
Precigen, Inc · Cervical Cancer, HPV-Related Carcinoma, HPV-Related Malignancy
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.